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ABSTRACT: Lankacidin C, which is an antibiotic produced
by the organism Streptomyces rochei, shows considerable
antitumor activity. The mechanism of its antitumor activity
remained elusive for decades until it was recently shown to
overstabilize microtubules by binding at the taxol binding site
of tubulin, causing mitotic arrest followed by apoptosis.
However, the exact binding mode of lankacidin C inside the
tubulin binding pocket remains unknown, an issue that
impedes proper structure-based design, modification, and
optimization of the drug. Here, we have used computational
methods to predict the most likely binding mode of lankacidin C to tubulin. We employed ensemble-based docking in different
software packages, supplemented with molecular dynamics simulation and subsequent binding-energy prediction. The
molecular dynamics simulations performed on lankacidin C were collectively 1.1 μs long. Also, a multiple-trajectory approach
was performed to assess the stability of different potential binding modes. The identified binding mode could serve as an ideal
starting point for structural modification and optimization of lankacidin C to enhance its affinity to the tubulin binding site and
therefore improve its antitumor activity.
1. INTRODUCTION
Lankacidin C is the parent of a group of antibiotics (T2636)
that are produced by the soil-dwelling bacteria Streptomyces
rochei. This group of antibiotics was first isolated in 1969 by
Harada and co-workers,1 and full characterization of the group
was achieved a few years later.2−5 Lankacidin C, Figure 1a,
possesses the structure of a 17-membered macrocyclic
polyketide and was found to have strong antimicrobial activity
against various Gram-positive bacteria, some of which are
resistant to macrolide antibiotics.6 The antimicrobial activity of
lankacidin C was found to be due to interference with peptide
bond formation during bacterial protein synthesis by binding at
the peptidyl transferase center of the eubacterial large
ribosomal subunit.7,8 Interest in lankacidin C has grown
recently, and several studies have been conducted with the aim
of facilitating its synthesis and large-scale production.9−11
Lankacidin C and various derivatives also displayed
considerable in vivo antitumor activity against various tumor
models such as 6C3 HED/OG lymphosarcoma, L1210
leukemia, and B16 melanoma,12,13 in addition to T47D breast
cancer cell lines.14 However, the mechanism of lankacidin C
antitumor activity remained unclear and was usually confused
with its mechanism of antimicrobial activity, until we recently
identified the mechanism. The mechanism of action was
predicted based on some computational simulations involving
compounds structurally very similar to lankacidin C.15 In our
recent work,14 we have shown that the mechanism of
lankacidin C antitumor activity is due to binding at the taxol
binding site of tubulin, which causes overstabilization of
cellular microtubules constituting the mitotic spindle. This
freezes the dividing cell at the metaphase, resulting in mitotic
arrest followed by apoptosis.
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Figure 1. Structure of (a) lankacidin C and (b) dictyostatin.
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Despite identifying the antitumor mechanism of action and
the tubulin binding site of lankacidin C, it is still unknown how
lankacidin C binds at the taxol binding site. X-ray crystallo-
graphic studies managed to identify the binding mode of
lankacidin C to the eubacterial large ribosomal subunit
associated with its antimicrobial activity.7,8 However, the
binding mode of lankacidin C to the taxol binding site of
tubulin, associated with its antitumor activity, remains
unknown. We have previously done some computational
simulations on lankacidin C and related analogues, and some
preliminary data on the binding mode were available.14,15
Nevertheless, a comprehensive study on the binding mode of
lankacidin C to tubulin was never performed. In this study, we
utilize cutting-edge computational techniques to identify the
binding mode of lankacidin C in the taxol binding site of
tubulin. We employ several ensemble-based docking experi-
ments, utilizing different computer software, to identify several
potential binding modes. The study is then supplemented with
single and parallel molecular dynamics (MD) simulations
(totaling 1.1 μs) and binding-energy calculations to assess the
various predicted binding modes and identify the most likely
one. The ensemble-based docking protocol is capable of
partially including receptor flexibility, whereas molecular
dynamics simulations can thereafter allow full receptor
flexibility. This approach was necessary since the taxol binding
site shows a great deal of induced fit and the binding pocket
can take several different shapes to accommodate a variety of
structurally diverse drugs, such as paclitaxel, discodermolide,
epothilone A, and dictyostatin. Figure 2 shows the different
shapes adopted by the taxol binding pocket while hosting those
different ligands. It also shows a root-mean-square deviation
(RMSD) matrix quantifying the structural differences between
the shapes of the binding pockets in each case. Excluding the
decent similarity between the binding pockets of 5MF4 and
5LXT (RMSD < 2.0 Å), the shapes of the binding pockets are
significantly different with RMSD values >2.0 Å. Furthermore,
we applied the same protocol outlined in this study to predict
the binding mode of dictyostatin (Figure 1b), whose
experimental binding mode is available through X-ray
crystallography (Protein Data Bank (PDB) ID: 5MF4). We
used this as a proof of concept to validate our protocol.
Finding out the correct binding pose of lankacidin C in the
taxol binding site should be of great importance and shall serve
as an excellent starting point for structure-based design of
lankacidin C. After the correct binding mode of lankacidin C is
established, the interactions inside the binding pocket can be
thoroughly studied and informed decisions regarding structural
modifications can be made. Such modifications can be made to
optimally exploit the binding cavity on the road to tailor-design
derivatives that should have better antitumor activity than the
parent lankacidin C.
2. RESULTS AND DISCUSSION
2.1. Ensemble-Based Docking. In this part, we docked
different lankacidin C conformers into a set of four different
conformations of the taxol binding pocket of tubulin using
GOLD and FRED docking software. Tubulin structures were
obtained from 1TVK (tubulin bound to epothilone A), 5MF4
Figure 2. Taxol binding site of tubulin shows a great deal of induced fit, posing a real challenge in docking of new ligands. (a) Binding pocket
changes shape to accommodate a variety of structurally diverse ligands, including paclitaxel (white, PDB ID: 3J6G16), discodermolide (green, PDB
ID: 5LXT17), epothilone A (purple, PDB ID: 1TVK18), and dictyostatin (red, PDB ID: 5MF419). (b) RMSD matrix of the binding pocket residues
of the four different aforementioned tubulin PDB structures in angstrom.
Table 1. Different Representative Binding Modes for Lankacidin C and Dictyostatin Obtained from GOLD and FRED
Docking Stepsa
lankacidin C dictyostatin
mode receptor rank score mode receptor rank score
GOLD1 1TVK 1 65.34 GOLD1 5MF4 1 70.04
GOLD3 1TVK 3 61.86 GOLD2 5LXT 2 69.40
GOLD6 1TVK 6 59.84 GOLD3 5LXT 3 68.88
GOLD12 1TVK 12 58.63 GOLD4 1TVK 4 68.76
FRED1 5LXT 1 −9.20 FRED1 5LXT 1 −6.95
FRED2 1TVK 2 −8.57 FRED2 1TVK 2 −6.76
FRED3 5MF4 3 −8.50 FRED3 3J6G 3 −6.46
FRED4 3J6G 4 −5.45 FRED4 5MF4 4 −5.67
aThe score in the case of GOLD is based on piecewise linear potential fitness and in the case of FRED is based on Chemgauss4 scoring function.
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(tubulin bound to dictyostatin), 5LXT (tubulin bound to
discodermolide) and 3J6G (tubulin bound to paclitaxel), all of
which are available on the Protein Data Bank. This helps
capture the binding site flexibility and account for induced fit.
Figure 3. Eight different binding modes selected through docking for (a) lankacidin C and (b) dictyostatin. The native binding mode for
dictyostatin is shown together with the GOLD1 binding mode in (a), colored in cyan.
Figure 4. Heavy-atom RMSD matrix quantifying, in angstrom, the differences between the eight different binding poses after fitting the atoms of
the binding pocket in the case of (a) lankacidin C and (b) dictyostatin.
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The ensemble-based docking returned a list of potential
binding modes that were ranked according to their scores, as
shown in Table 1. We selected a set of representative binding
modes from each docking protocol. In the case of GOLD
docking, the results of the ensemble-based docking from all
protein conformations were compiled together and the best-
ranked docking poses were visually compared. The poses were
narrowed down to the first four unique binding modes. In the
case of lankacidin C, those four unique binding modes were
named GOLD1, GOLD3, GOLD6, and GOLD12, each of
which represents a specific lankacidin C conformation and
orientation inside a specific protein conformation. These
binding modes are numbered according to their scoring ranks.
It was found that all of these poses came from the protein
conformation in 1TVK. In the case of FRED docking, each of
the four docking runs was treated separately. The poses from
each run, i.e., against each protein conformation, were ranked
separately, and the best-scoring pose was selected. The reason
we did this is that GOLD docking returned all of the best
results from the 1TVK protein conformation. Therefore, in the
FRED docking, we wanted to make sure that we take the best
pose from each of the different protein conformations to make
sure we cover all of the available protein conformational space
in our analysis. The four binding modes resulting from FRED
run were ranked according to their Chemgauss4 score as listed
in Table 1. From the results of docking, the binding modes
GOLD1 and FRED1 are the highest-ranked binding modes
according to the two different docking algorithms. Therefore,
one of these two modes is likely to be the correct binding
mode. This hypothesis will be tested in the next sections.
Figure 3a shows each of the eight different binding modes
identified in the ensemble-based docking runs. The figure
shows how the orientation of the ligand can sometimes be
completely different as some of the poses are 180° flipped with
respect to the others. Figure 4a shows a matrix of the RMSD of
the ligand heavy atoms between the eight different binding
modes after fitting the atoms in the binding pocket. The matrix
shows that some modes are similar, whereas others are
completely different. Most of the modes obtained from GOLD
are significantly different with many RMSD values significantly
greater than 2.0 Å. This is expected since these modes were
carefully selected from the top-scoring poses to maximize
diversity and uniqueness. Other modes, especially those
obtained from FRED, are relatively more similar since pose
diversity was not the factor in choosing them, rather receptor
conformation diversity. Examining the results of the ensemble-
based docking of dictyostatin presented in Table 1, we can see
that GOLD and FRED protocols similarly returned four
binding modes each. The best mode in GOLD docking,
GOLD1, was bound to the receptor conformation coming
from 5MF4, whereas in the case of FRED docking, it came
from the receptor conformation in 5LXT. Since the native
crystal structure of dictyostatin is indeed found in 5MF4, the
GOLD docking protocol seems to have performed better this
time. The binding modes are all shown in Figure 3b, and an
RMSD matrix is shown in Figure 4b. Comparing all of the
binding modes to the native crystal structure of dictyostatin
bound to tubulin, it is clear that the GOLD1 binding mode is
the closest one to the native structure. The GOLD1 binding
mode is shown overlaid to the native crystal structure in Figure
3b. On the other hand, the RMSD matrix in Figure 4b shows
that GOLD1 is only 1.14 Å different from the native binding
mode, whereas all other binding modes are at least 4.82 Å
different. In short, these findings manifest the ability of our
docking protocol to find the correct binding mode of
dictyostatin.
Despite the good performance of the docking protocol in the
case of dictyostatin, most of the time the results of docking and
scoring are questionable even when ensemble-based docking is
performed. This is because to assess the binding mode
correctly, both the ligand and the protein have to be
completely free to explore different conformations in the
bound state. In addition, the binding energy (BE) between the
two entities should be calculated as an ensemble average or a
time average taking into account all of the conformations
explored by the bound ligand−protein complex in comparison
to the free ligand and protein. Equation 1 shows how the
ensemble average of a property A, in our case it is the energy,
which is a function of positions (q) and momenta (p), is
calculated. In this case, the Boltzmann factor (e−E(p,q)/kT) is
used as a weighting factor, where E is the energy of the
microstate, k is the Boltzmann constant, and T is the
temperature in kelvin. The integration is done over the entire
phase space.
∬
∬
⟨ ⟩ =
−
−A
A p q p q
p q
( , ) e d d
e d d
E kT
E kT
p q
p qensemble
( , )/
( , )/
(1)
The time average of property A can also be calculated
according to eq 2, where the positions and momenta are now
functions of time, which extends from zero to ∞.
∫τ⟨ ⟩ = τ
τ
→∞ =
t t tA A p qlim
1
( ( ), ( )) d
t
time
0 (2)
The ergodic hypothesis maintains that in ergodic systems, the
ensemble average is equal to the time average as demonstrated
in eq 3. This is where molecular dynamics comes into play
where the system is simulated for a finite period of time hoping
that this simulation will capture the most important micro-
states of the system. After that, a representative set of
microstates M (i.e., conformations of the bound complex) is
used to approximate the time average of property A as shown
in eq 3.20
∑⟨ ⟩ = ⟨ ⟩ ≈
=M
tA A A
1
( )
i
M
iensemble time
1 (3)
In our case, the property we are interested in is the potential
energy of the system. The binding energy will be calculated as
the difference between the average energy of the complex and
the average energies of the ligand and receptor, as shown in eq
4.
⟨Δ ⟩ = ⟨ ⟩ − ⟨ ⟩ − ⟨ ⟩E E E Ebinding complex receptor ligand (4)
For this reason, molecular dynamics simulation is necessary to
generate a set of representative conformations of the ligand−
protein complex, which can be used to assess the stability of
the complex and more importantly to re-evaluate the scores of
each of the eight binding modes obtained from the docking
experiment.
2.2. Molecular Dynamics Simulations. Molecular
dynamics simulations were performed for the eight ligand−
protein complexes representing the eight different binding
modes identified in the docking steps. The stability of the
protein (tubulin), as well as that of the ligand (lankacidin C) in
the binding site, was assessed by following the root-mean-
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squared deviation (RMSD) change over the course of the
simulation time as shown in Figure 5a. The RMSD was
measured after least-square fitting of the Cα atoms of the
protein to that of the initial structure before the simulations.
The figure shows that the RMSD of the protein (black lines) is
stable for most of the complexes, ranging from 2.0 to 3.0 Å.
The most stable protein among all of the complexes is the
protein in the FRED1 binding mode where the RMSD of the
protein is stabilized early in the simulation with very little
fluctuations all around an average RMSD value of 1.3 Å. This
means that for FRED1 binding mode, the protein stays for the
whole 50 ns of the simulation in a conformation very close to
the starting conformation obtained from 5LXT. Having an
RMSD of less than 2.0 Å usually means that the conformation
is almost unchanged.
Analyzing the change in RMSD of the ligand in Figure 5a,
we find large values of RMSD as well as large fluctuations in
the case of GOLD12, FRED3, FRED4, FRED2, GOLD3, and
GOLD1 binding modes. The large values of RMSD (>2.0 Å)
indicate that the binding mode of the ligand has changed over
the course of the simulation time and it no longer resembles
the initial binding mode. Not only are the values of RMSD
large, but there are also large fluctuations in the values of
RMSD over the course of the 50 ns of the simulation
indicating that the ligand cannot attain a stable orientation in
the binding pocket. The ligand is stuck oscillating in the
middle of some unfavorable orientations that cannot be easily
changed to a favorable one due to the presence of high energy
barriers. Therefore, it is unlikely that any of the six
aforementioned modes will be the correct binding mode. For
the two remaining modes, namely, FRED1 and GOLD6, the
case is different. The RMSD fluctuations are small and the
values are all around 2.0 Å, indicating that the ligand is stable
in this binding mode and that the initial binding mode before
the simulation is nearly conserved. The FRED1 binding mode
is even more stable. Despite some fluctuations in the first 8 ns,
the ligand remains around an RMSD value of nearly 1.2 Å until
the end of the simulation, in contrast to an average value of 2.4
Å for GOLD6. This means that during the first 8 ns, the ligand
and the protein in the FRED1 binding mode were slightly
rearranged in space to accommodate each other better. After
that, the ligand remained in an essentially unchanged
orientation, very similar to the starting orientation, for the
remaining 42 ns of the simulation. This is another evidence
increasing the likelihood that FRED1 is the correct binding
mode of lankacidin C to tubulin, despite the GOLD6 binding
mode being a strong competitor.
Analyzing the RMSD plots of dictyostatin−tubulin com-
plexes shown in Figure 5b, we can similarly rule out GOLD4,
FRED1, FRED2, and FRED4. They are very unlikely to be the
Figure 5. RMSD change over the course of the simulation for the different binding modes of (a) lankacidin C and (b) dictyostatin. The black lines
represent the RMSD of the Cα atoms of the protein. The red lines (usually higher in the plots) represent the RMSD of the ligand atoms. All RMSD
values were obtained after least-square fitting of the Cα atoms of the protein and with respect to the initial structure before the simulations.
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correct binding modes amid the instability reflected through
their RMSD plots. To a lesser extent, GOLD3 and GOLD2
also are unlikely to be the correct binding modes since their
ligand RMSD values are greater than 2.0 Å, and less but
significant fluctuations can also be seen. We are left with
GOLD1 and FRED3 binding modes, where the RMSD of both
the ligand and the protein reflects a great deal of stability. In
the case of GOLD1, the average value of ligand RMSD after
the first 10 ns is 1.6 Å, versus 2.0 Å in case of FRED3. Indeed,
the GOLD1 binding mode is the most stable among the eight
proposed binding modes, which agrees with the fact that it is
the correct binding mode. Once again, this strongly supports
our approach in this study and highlights the reliability of using
RMSD as a measure of binding mode stability and likelihood
of being the correct one.
A hydrogen bond analysis was done to study the hydrogen
bonds between lankacidin C and the protein along the 50 ns
simulation trajectory of each of the eight complexes. The
results are presented in Figure 6. The frequency of the
hydrogen bonds over the simulation time as shown in the
figure can indicate that the binding modes FRED3, FRED4,
and GOLD1 are unlikely to be the correct binding modes due
to the low frequency of hydrogen bonds. Other modes such as
GOLD12, FRED2, FRED1, GOLD6, and GOLD3 have higher
hydrogen bond frequencies, and one of them is more likely to
be the correct binding mode. It is worth mentioning that the
frequency of hydrogen bonds alone, without considering the
strength of each bond, is not enough measure for the strength
of binding since few strong hydrogen bonds can make a bigger
contribution to binding than many weak hydrogen bonds.
Therefore, the results of this analysis can only be taken as a
rough estimation. A deeper analysis of the binding energy can
be achieved with molecular mechanics/Poisson−Boltzmann
surface area (MM/PBSA) calculations.
2.3. MM/PBSA Binding-Energy Calculations. The
binding energy was estimated using the MM/PBSA method,
which takes into account contributions due to van der Waals
(vdW) and electrostatic interactions (ele) (utilizing molecular
mechanics, MM), polar solvation (PS) energy (utilizing
Poisson−Boltzmann (PB) method), and nonpolar solvent-
accessible surface area energy (utilizing a surface area term,
SA). This, however, does not take into account the
contributions due to rotational, translational, or vibrational
entropy. Since in our study we are comparing the same ligand
bound to the same protein but only in different binding modes,
the entropic contributions are not expected to be much
different between different binding modes. This is why the
costly entropic calculations via normal mode analysis were not
necessary and we depended on MM/PBSA alone to compare
the different binding modes.
The results of MM/PBSA and its different contributions in
the eight different binding modes of lankacidin C are shown in
Table 2. As expected, the list is topped by the FRED1 binding
mode with an average binding energy of −99 kJ/mol over the
Figure 6. Results of the analysis of hydrogen bonds between lankacidin C and the protein along the 50 ns trajectories of the eight complexes. The x
axis shows the frame number at a density of 100 frames/ns. The numbers to the right of each plot represent the persistence percentage of single,
double, and triple hydrogen bonds (bottom to top) over the entire simulation time.
Table 2. MM/PBSA Binding Energies (BE) in kJ/mol between the Ligand (Lankacidin C or Dictyostatin) and the Protein in
the Eight Binding Modesa
lankacidin C dictyostatin
mode vdW ele PS NPS BE mode vdW ele PS NPS BE
FRED1 −190 −41 152 −20 −99 ± 16 GOLD1 −213 −83 164 −22 −154 ± 17
FRED2 −203 −40 165 −21 −99 ± 17 GOLD2 −209 −52 157 −23 −127 ± 16
GOLD1 −133 −40 100 −17 −90 ± 13 FRED3 −242 −22 177 −25 −112 ± 16
GOLD6 −175 −36 145 −20 −86 ± 20 GOLD3 −173 −41 128 −20 −106 ± 18
GOLD12 −124 −43 104 −15 −78 ± 20 FRED2 −162 −25 106 −19 −100 ± 15
FRED3 −159 −25 125 −18 −77 ± 17 GOLD4 −189 −20 128 −22 −103 ± 21
GOLD3 −134 −56 132 −17 −75 ± 22 FRED4 −160 −25 107 −21 −99 ± 20
FRED4 −155 −39 156 −20 −58 ± 13 FRED1 −177 −11 113 −22 −97 ± 16
aThe table shows different contributions to the binding energy including van der Waals (vdW) interactions, electrostatic interactions (ele), polar
solvation (PS), and nonpolar solvation (NPS).
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course of the trajectory. An equal binding energy was also
reported for FRED2 binding mode. All of the remaining
binding modes have significantly weaker binding than the first
two with the third-ranking mode, GOLD1, being statistically
lower than the first two in a confidence interval greater than
99%. Most of that difference in binding energy comes from van
der Waals interactions and polar solvation energy. With regards
to dictyostatin, Table 2 shows that the GOLD1 binding mode
is at the top of the list with an average binding energy of −154
kJ/mol. Thus, the binding in the case of the GOLD1 binding
mode is significantly stronger than the binding in the case of all
of the other binding modes. This is in line with all of the
previous findings that GOLD1 is the most stable binding mode
besides being the native binding mode found in the
experimental structure. In turn, it is another evidence boosting
the reliability of the protocol used in this study. In addition,
upon comparing the binding energy of the best-scoring binding
mode of dictyostatin (−154 kJ/mol) and the best-scoring
binding mode of lankacidin C (−99 kJ/mol), we find that the
results agree very well with experimental data. The IC50 of the
cytotoxic activity of dictyostatin lies in the nanomolar range,19
whereas that of lankacidin C lies in the micromolar range.14
Both our estimates of the binding energies and the
experimental values of IC50 reflect that dictyostatin has a
cytotoxicity that is orders of magnitude stronger than that of
lankacidin C.
2.4. Multiple-Trajectory Approach. To evade the risks
that emerge from relying on a single molecular dynamics
simulation, we ran a multiple-trajectory analysis to further
assess the stability of the binding modes. In the multiple-
trajectory simulations, five different parallel molecular
dynamics runs were carried out for each of the eight binding
modes of lankacidin C, each of the runs was 10 ns long. Each
of the five parallel runs starts with a different velocity
distribution, and hence the trajectories should be uncorrelated.
Thus, we rule out the possibility that a single trajectory may be
stable simply because of a specific favorable initial velocity
distribution, or vice versa. As outlined in the methods section,
a certain binding mode would be judged as a stable binding
mode if at least one of the five parallel runs achieved an average
ligand RMSD value <2.0 Å relative to the starting structure
before the simulation. This criterion, as well as the entire
method, was tested and validated recently.21,22 The average
RMSD values for all of the runs are listed in Table 3. As the
table shows, the only binding mode that attained an average
RMSD value of <2.0 Å at least once is FRED1. In fact, not only
one but two out of the five parallel simulations, namely, MD1
and MD2, satisfied this stability criterion. Therefore, it is the
most likely binding mode compared to the others. All other
binding modes did not satisfy this stability criterion, which
indicates the very low likelihood that any of them could be the
correct binding mode. Table 3, however, also shows that the
MD3, MD4, and MD5 runs of the FRED1 binding mode did
not satisfy our stability criterion. This behavior is acceptable
due to the fact that each simulation run possibly explores a
different region of the molecular dynamics phase space
trajectory. Therefore, one should not expect every simulation
run to achieve perfect stability, which does not happen even in
real life as the ligand dynamically associates and then
dissociates from the receptor. This is why the parallel
molecular dynamics approach is preferable for such inves-
tigations and that is why our criteria for stability only required
a minimum of one of the five simulations to achieve stability, as
similarly argued by Liu and Kokubo.21,22 Nevertheless, we
wanted to investigate what could happen if we extend the five
simulations of FRED1 to about 40 ns and measure the average
RMSD in the last 10 ns of the simulation. We also did the same
to the GOLD6 binding mode, which was the strongest
competitor to FRED1 based on the previous RMSD analysis
(see Figure 5). The results of the extended simulations
indicated that for FRED1, the average RMSD values for both
MD1 and MD2 remained below 2.0 Å, with values of 1.7 and
1.1 Å, respectively. MD5 also attained an average RMSD value
of 1.0 Å early after the first 15 ns of the simulation. Therefore,
three of the five extended runs meet our stability criterion. The
average RMSD value of the MD3 run considerably declined
from 5.6 Å to nearly 2.2 Å, but this does not meet our stability
criterion. On the other hand, the average RMSD value of MD4
remained around 5.4 Å and never went down below 2.0 Å. For
the GOLD6 binding mode, the average RMSD values of all of
the five extended simulation runs remained above the cutoff of
2.0 Å, the lowest of which was the MD5 run, which had an
average RMSD value slightly above 2.0 Å. The other four runs
had average RMSD values ranging from 2.5 to 7.4 Å.
Therefore, three out of the five extended runs for FRED1
showed adequate stability, whereas none of the five runs for
GOLD6 met the preset stability criterion.
Given those findings, the FRED1 binding mode emerges as
the most likely binding mode of lankacidin C in the taxol
binding site. This mode showed a high score in docking,
demonstrated a great deal of stability in RMSD analysis,
performed decently in hydrogen bond analysis, and most
importantly achieved the highest score in the MM/PBSA
calculations as well as the multiple-trajectory approach. Despite
the high score of the FRED2 binding mode of lankacidin C in
the MM/PBSA analysis, its relatively poor performance in the
RMSD analysis and the multiple-trajectory approach makes it
less likely to be the correct binding mode due to the
considerable instability of the ligand in its binding pocket. In
addition, although GOLD6 performed well in RMSD analysis,
its poor score in the MM/PBSA analysis and the multiple-
trajectory approach makes it unlikely to be the correct binding
mode. It is interesting to mention that the FRED1 binding
mode of lankacidin C identified in this study is significantly
different from the preliminary binding mode that was
previously proposed14,15 but never tested thoroughly, and
this is part of the reason why this study was conducted.
Table 3. Average Lankacidin C RMSD Values of the Last
Nanosecond in Each of the Five Parallel Molecular
Dynamics Simulation Runs, Each of Which Is 10 ns Longa
mode MD1 MD2 MD3 MD4 MD5
GOLD1 2.6 4.4 7.7 5.7 6.1
GOLD3 6.3 3.9 4.2 3.5 9.0
GOLD6 3.5 2.4 3.9 3.6 2.0
GOLD12 4.5 2.2 4.8 5.2 5.0
FRED1 1.1b 1.0b 5.6 5.6 2.3
FRED2 4.1 4.4 3.9 3.7 2.8
FRED3 2.0 6.5 5.0 4.5 2.9
FRED4 2.6 10.9 4.6 4.1 3.9
aOnly the FRED1 binding mode can be judged as stable according to
our definition of stability. bBold entries highlight the RMSD values
that are less than 2.0 Å and thus meet the stability criteria.
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Visual analysis of the FRED1 binding mode, see the
Supporting Information for an animation of the entire
trajectory, reveals a ligand that is very stable in its binding
pocket, very well buried inside the pocket with strong
persistent interactions with nearby residues as was shown in
the hydrogen bond analysis. Figure 7 shows the binding
interactions of lankacidin C in the FRED1 binding mode as
well as dictyostatin in the native binding mode inside the taxol
binding site of tubulin. The figure shows that lankacidin C
makes hydrogen bonds with the side chain of Asp226 and the
backbones of Thr276 and His229, whereas dictyostatin makes
hydrogen bonds with the backbones of Thr276, Gln282, and
Pro274.
3. CONCLUSIONS
In this study, we have identified the most likely binding mode
of lankacidin C in the taxol binding site of tubulin utilizing
computational techniques. Eight different binding modes were
proposed based on an ensemble-based docking experiment,
which partially takes the receptor flexibility into account. After
that, a molecular dynamics simulation was performed to assess
the stability of each of the eight binding modes, allowing for
full protein and ligand flexibility. RMSD analysis revealed that
the FRED1 binding mode was the most stable among the
binding modes. Hydrogen bond analysis showed that the
FRED1 binding mode shows up on top of the list of hydrogen
bond frequencies, despite being competed with GOLD12 and
FRED2, both of which have already been ruled out due to
instability in RMSD analysis. MM/PBSA binding-energy
calculations revealed that the FRED1 binding mode is the
best-scoring mode in terms of binding energy. Multiple-
trajectory approach revealed that only the FRED1 binding
mode met the required criterion for stability. Overall, the
results indicate that the FRED1 binding mode is the most
likely one among the eight studied binding modes. The
coordinates of the FRED1 complex are available in the
Supporting Information. The inclusion of dictyostatin in the
study served as a benchmark for validating the reliability of the
method for binding mode prediction. This study, however,
needs to be confirmed through experimental techniques such
as X-ray crystallography, which is part of our future plans.
Upon establishing the binding mode of lankacidin C to the
taxol binding site, structure-based design techniques can
immediately be applied to optimize the binding of lankacidin
C to tubulin and improve its antitumor activity to compete
with other antitumor drugs available in the market.
4. EXPERIMENTAL SECTION
This study was performed in four consecutive steps. First, an
ensemble-based docking was performed to identify a group of
potential binding modes of lankacidin C in the taxol binding
site of tubulin. Second, the tubulin−lankacidin C complex of
each of the different binding modes was studied using all-atom,
explicit solvent molecular dynamics simulations. The molecular
dynamics trajectories were studied to assess the stability of the
complexes. Third, the trajectories were used to estimate the
binding energy between the ligand and the protein in each
binding mode using the MM/PBSA method. Finally, a
multiple-trajectory approach was followed to further assess
the stability of each binding mode. In addition, validating this
protocol required that we apply the same steps to dictyostatin,
whose native crystal structure with tubulin is available, to make
sure that the protocol is able to predict its binding mode
correctly. The reason we choose dictyostatin is its structural
similarity to lankacidin C.
4.1. Ensemble-Based Docking. In ensemble-based
docking, an ensemble of different receptor binding site
conformations is used for docking, in an effort to account
for receptor flexibility in the docking process. The ligand is
docked into the binding site of each of these different
conformations, and the different binding poses are ranked
according to some scoring function. In this study and to obtain
an ensemble of different tubulin binding site conformations, we
screened the Protein Data Bank for entries of tubulin bound to
various structurally diverse molecules at the taxol binding site.
The search returned four distinct tubulin−ligand complexes
including tubulin−paclitaxel complex with the PDB ID:
3J6G,16 tubulin−discodermolide complex with the PDB ID:
5LXT,17 tubulin−epothilone A complex with the PDB ID:
1TVK,18 and tubulin−dictyostatin complex with the PDB ID:
Figure 7. Interactions between the tubulin taxol binding site and (a) lankacidin C in the FRED1 binding mode or (b) dictyostatin in the native
binding mode.
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5MFA.19 The binding pocket of each of these complexes takes
a different shape to accommodate the ligand; see Figure 2.
Each of these complexes was cleaned by the elimination of the
unnecessary α-tubulin subunit and retention of the β subunit
where the binding pocket is located. Molecular Operating
Environment (MOE, 2012)23 was used for receptor prepara-
tion and the addition of missing hydrogen atoms via
protonate3D, which optimizes the tautomeric forms of residues
such as histidine and allows flipping of amide groups of side
chains to optimize protonation.
The ensemble-based docking was done twice: once utilizing
GOLD 5.6.3 (CCDC)24 and another time utilizing FRED
from the OEDocking 3.2.0 suite (OpenEye).25,26 In each case,
a slightly different protocol was applied to make sure we try as
many different protocols as possible. In GOLD docking, the
processed β subunits of the proteins from the four different
PDB structures were superimposed and were ready for
docking. As to the ligand, the crystal structure of lankacidin
C was downloaded from the Protein Data Bank, PDB ID:
3JQ4.7 MOE was utilized to perform a stochastic conforma-
tional search for lankacidin C to capture the flexibility of the
17-membered macrocyclic ring. A database of the low-energy
conformations of lankacidin C was then used for docking
against the ensemble of protein conformations superimposed
by GOLD in the previous step. In the docking protocol, the
binding site was defined to be within 6.0 Å of the co-
crystallized ligands in the taxol binding site; pyramidal N and
ring corners were allowed to flip; and CHEMPLP was used as
a scoring function, without early termination to generate
diverse solutions. The solutions were then analyzed visually,
and the best-ranked poses were classified into a set of four
distinct modes. The complex of each mode together with its
corresponding tubulin conformation was later taken into a
molecular dynamics simulation for further assessment of the
complex stability and binding energy.
As to the docking step performed by FRED, the β subunit of
the four different tubulin conformations was processed
similarly using the make_receptor module. Lankacidin C was
then subjected to a conformational search using OMEGA
3.2,27 allowing the macrocycle to be flexible to explore different
ring conformations. The ensemble of lankacidin C conforma-
tions was then docked separately to each of the four different
tubulin receptor conformations. The different poses were
scored using the Chemgauss4 scoring function to identify the
best-scoring poses in each of the four docking runs. Out of
each of these runs, we separated the best-scoring pose of
lankacidin C in the complex with the respective tubulin
receptor conformation, ending up with four potential binding
modes. These binding modes were also taken into molecular
dynamics simulations to assess their stability and estimate the
binding energy. Thus, in total, we ended up with four binding
modes from GOLD and another four binding modes from
FRED. Similarly, we applied the same aforementioned docking
protocol to dock dictyostatin, whose experimental structure is
available, to the taxol binding site to assess the ability of the
protocol to find the correct binding mode. We made sure that
we randomize the structure of dictyostatin before docking to
eliminate any bias in the docking process.
4.2. Molecular Dynamics Simulations. The docking step
generated a set of potential binding modes for lankacidin C
with different conformations of tubulin. A complex of the
ligand and the corresponding tubulin conformation for each of
the identified distinct binding modes was further analyzed by
molecular dynamics. The GROMACS 2016.3 molecular
dynamics package was used for this purpose.28 We used the
force field AMBER99SB-ILDN for the protein,29 the GAFF
force field for lankacidin C,30 and the polyphosphate
parameters developed by Meagher et al.31 for parameterizing
the guanosine diphosphate cofactor in β-tubulin. We utilized
ACPYPE script to facilitate ligand parameterization.32 Each
complex was then solvated in a dodecahedral water box
extending at least 10.0 Å in every direction, using the TIP3P
water model. The system was then neutralized by the addition
of sodium ions. Extra sodium chloride was added to adjust the
salt concentration to 150 mM. The system was then minimized
using the steepest descent algorithm. This was followed with
100 ps NVT equilibration at 300 K with position restraints on
the protein and ligands. Subsequently, 100 ps of NPT
equilibration at 1.0 bar was performed under the same
position restraints. In all of the dynamics, a short-range cutoff
of 12.0 Å was used for nonbonded interactions. In the end, the
position restraints were released and a production phase of 50
ns followed under the same conditions as described before,
saving coordinates every 10 ps. Thus, considering the eight
different binding modes, we have performed a total of 8 × 50 =
400 ns simulations of the lankacidin−tubulin complex. All of
these simulations were performed on NVIDIA Tesla K80
Graphical Processing Units on Bibliotheca Alexandrina High-
Performance Computing Cluster (BA-HPC), Alexandria,
Egypt. The trajectories were later analyzed by assessing the
RMSD of the protein and ligand. This was done after least-
square fitting of the Cα atoms of the protein and with respect
to the initial structure before the simulation. Also, a hydrogen
bond analysis between the ligand and the protein in each
complex was performed over the entire trajectory, utilizing
VMD 1.9.4a12,33 using default values of a cutoff distance of 3.0
Å and a cutoff angle of 20°. Binding energies were analyzed as
will be described in the following section. Similarly, this
protocol was also applied to dictyostatin as a proof of concept.
4.3. MM/PBSA Binding-Energy Calculations. The
molecular dynamics trajectory of each of the studied complexes
was used to estimate the binding energy between the ligand
and the receptor using the MM/PBSA method. This method
divides the binding energy into three components assessed
with three different methods. The first component is
nonbonded interactions between the ligand and the receptor
(van der Waals and electrostatic interactions), which is
assessed using molecular mechanics (MM). The second
component is the electrostatic contribution to the solvation
free energy, which is assessed using the linearized Poisson−
Boltzmann (PB) method. The third component is the
hydrophobic contribution to the solvation free energy, which
is calculated using a surface area (SA) term. For this sake, we
have discarded the first 5 ns from each trajectory and used the
remaining 45 ns for the MM/PBSA calculation at 250 ps
intervals, for a total of 180 frames. We used the g_mmpbsa
script developed by Kumari et al.34,35 for the MM/PBSA
calculations. We used a solute dielectric constant of 2 and a
solvent dielectric constant of 80 for electrostatics. We used the
default values for surface tension (γ = 0.0226778 kJ/(mol Å2)),
probe radius (1.4 Å), and an offset constant of 3.84982 kJ/mol
for the surface area term. Default values were used for the
remaining parameters of the calculation. The binding energies
of all different binding modes were compared, and the best-
scoring mode was obtained. These calculations were done for
both lankacidin C and dictyostatin.
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4.4. Multiple-Trajectory Approach. A multiple-trajectory
analysis was performed to further assess the stability of each
binding mode of lankacidin C. All of the eight binding modes
were taken into a molecular dynamics simulation using the
same conditions and parameters described in the previous
simulation. This time, for each binding mode, five independent
parallel molecular dynamics simulation runs were performed,
each having a production phase of 10 ns length. Thus, the
initial velocity distributions generated in each of the five runs
should be different and the trajectories should be uncorrelated.
Hence, in total, 10 × 5 × 8 = 400 ns simulations were
performed in this step. After that, the trajectory of each run
was analyzed by considering 100 snapshots from the last 1 ns
of the 10 ns trajectory. The average RMSD value of the ligand
heavy atoms was calculated over these 100 snapshots, after
fitting the protein backbone atoms to the initial protein
structure before the simulation. For each of the eight binding
modes, the average RMSD value for each of the five
independent simulations was assessed, and if the value of at
least one of these five runs was less than 2.0 Å, the ligand was
judged to be stable in this binding mode. This approach was
outlined by Liu and Kokubo in previous studies and was shown
to be effective in assessing the stability of different binding
modes.21,22 Based on the results of this analysis, some of the
simulation runs were extended from 10 to 40 ns to further
confirm persistent stability or instability. This resulted in a
total of extra 300 ns simulation time. Collectively, the length of
the molecular dynamics simulations applied to lankacidin C−
tubulin complex in the parallel runs outlined in this section as
well as the single runs outlined in Section 4.2 was 400 + 300 +
400 = 1100 ns or 1.1 μs.
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